Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete …

MS Tallman, GW Dewald, S Gandham… - Blood, The Journal …, 2007 - ashpublications.org
We compared the treatment-related mortality, relapse rate, disease-free survival (DFS), and
overall survival (OS) by cytogenetic risk group of 261 patients with acute myeloid leukemia …

Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete …

MS Tallman, GW Dewald, S Gandham… - …, 2007 - mayoclinic.elsevierpure.com
We compared the treatment-related mortality, relapse rate, disease-free survival (DFS), and
overall survival (OS) by cytogenetic risk group of 261 patients with acute myeloid leukemia …

Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete …

MS Tallman, GW Dewald, S Gandham, BR Logan… - Blood, 2007 - europepmc.org
We compared the treatment-related mortality, relapse rate, disease-free survival (DFS), and
overall survival (OS) by cytogenetic risk group of 261 patients with acute myeloid leukemia …

[HTML][HTML] Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete …

MS Tallman, GW Dewald, S Gandham, BR Logan… - Blood, 2007 - ncbi.nlm.nih.gov
We compared the treatment-related mortality, relapse rate, disease-free survival (DFS), and
overall survival (OS) by cytogenetic risk group of 261 patients with acute myeloid leukemia …

Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete …

MS Tallman, GW Dewald, S Gandham, BR Logan… - Blood, 2007 - experts.umn.edu
We compared the treatment-related mortality, relapse rate, disease-free survival (DFS), and
overall survival (OS) by cytogenetic risk group of 261 patients with acute myeloid leukemia …

Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete …

MS Tallman, GW Dewald, S Gandham, BR Logan… - …, 2007 - scholars.northwestern.edu
We compared the treatment-related mortality, relapse rate, disease-free survival (DFS), and
overall survival (OS) by cytogenetic risk group of 261 patients with acute myeloid leukemia …

[引用][C] Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete …

MS TALLMAN, GW DEWALD, JM ROWE… - Blood, 2007 - pascal-francis.inist.fr
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell
transplantation for acute myeloid leukemia in first or second complete remission CNRS Inist …

Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete …

MS Tallman, GW Dewald, S Gandham, BR Logan… - …, 2007 - pubmed.ncbi.nlm.nih.gov
We compared the treatment-related mortality, relapse rate, disease-free survival (DFS), and
overall survival (OS) by cytogenetic risk group of 261 patients with acute myeloid leukemia …

Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete …

MS Tallman, GW Dewald, S Gandham, BR Logan… - Blood, 2007 - cir.nii.ac.jp
抄録< jats: p> We compared the treatment-related mortality, relapse rate, disease-free
survival (DFS), and overall survival (OS) by cytogenetic risk group of 261 patients with acute …

[HTML][HTML] Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete …

MS Tallman, GW Dewald, S Gandham, BR Logan… - Blood, 2007 - Elsevier
We compared the treatment-related mortality, relapse rate, disease-free survival (DFS), and
overall survival (OS) by cytogenetic risk group of 261 patients with acute myeloid leukemia …